Full Process Analysis of Importing European High-end Medical Devices via Tianjin Freight Forwarding

Background and Pain Points of Importing European High-end Medical Devices in Tianjin in 2026

In 2026,Tianjin Port,as the core international port in northern China,saw an 18% year-on-year increase in the import volume of high-end European medical devices,among which in vitro diagnostic reagents and rehabilitation equipment accounted for more than 60%.These products have high technical content and strict compliance requirements,and many local medical enterprises in Tianjin reported frequent import bottlenecks: some were rejected by customs due to mismatched EU MDR certification versions,some were detained in the port for more than 5 days due to unqualified commodity inspection sampling,and others incurred additional exchange rate differences due to poor connection of foreign exchange payment and collection processes.

Common Import Difficulties

• The new version of the EU MDR regulations will be mandatory starting from 2026,and the old CE certification will no longer be valid for customs clearance
• Tianjin Port has upgraded the biocompatibility testing requirements for medical devices,requiring reports issued by CNAS-accredited institutions
• Cross-border foreign exchange payment and collection must comply with the latest "Trade Foreign Exchange Receipt and Payment Convenience" policy,and some small and medium-sized enterprises have delayed fund arrival due to unfamiliar operations

Core Role of Zhongshen in European Medical Device Imports

Zhongshen has been engaged in foreign trade agency for more than 20 years.For the scenario of importing European medical devices through Tianjin Port,it can connect with the customs special goods supervision channel and the commodity inspection designated testing agency in advance,and also cooperate with the EU Authorized Representative (AR) to assist in updating certification documents.Last year,12 local medical enterprises in Tianjin imported similar products through its agency,with an average customs clearance time shortened by 4 days compared with the industry average.

Import Process Breakdown and Compliance Handling

1.Document Pre-check Stage: Focus on Core Details of MDR Certification

The first hurdle for importing European medical devices is document compliance.The key change in 2026 is that MDR certificates must be issued by EU Notified Bodies (NB) and marked "2026 Version".Zhongshen will pre-check the full set of documents 10 working days before the goods are shipped:

• Verify the qualification of the issuing institution of the MDR certificate (to avoid invalid certificates issued by non-NB institutions)
• Confirm that the technical document DOC includes the 2026 version risk analysis report and clinical evaluation data
• Verify that the contact information of the EU Authorized Representative (AR) matches the product authorization scope

Last year,the medical technology company where Mr.Fu worked submitted the old version of the MDR certificate due to negligence.After Zhongshen found this during the pre-check,it immediately contacted the cooperating German NB institution and assisted in supplementing the new version of the certification document within 3 working days,avoiding direct return of the goods after they arrived at the port.

2.Port Customs Declaration Stage: Connect to Customs Special Channels

Tianjin Customs implements "advance declaration + classified supervision" for medical devices.Zhongshen will complete the single window declaration 24 hours before the goods arrive at the port and connect with the Customs Special Goods Supervision Section in advance:

For Class III medical devices imported for the first time,a copy of the Import Medical Device Registration Certificate must be submitted simultaneously; for registered products,the Medical Device Business License must be provided.Last year,a batch of rehabilitation equipment imported from Germany was required by customs to supplement clinical use cases because "medical grade" was noted in the declaration.Zhongshen coordinated with the customer to provide the use report from EU hospitals within 1 hour and completed the inspection and release on the same day.

3.Commodity Inspection and Quarantine Stage: Coordinate Designated Testing Institutions

In 2026,Tianjin Commodity Inspection has increased the sampling rate for European medical devices to 15%,adding biocompatibility testing requirements.Zhongshen’s approach is:

Contact the CNAS-accredited testing institution designated by Tianjin Commodity Inspection in advance to confirm the sampling time and testing cycle; if index deviations are found during testing,assist customers in preparing rectification plans (such as supplementing product sterilization certificates) to avoid repeated sampling.Last year,a batch of in vitro diagnostic reagents imported from France slightly exceeded the standard in the "cytotoxicity" indicator during biocompatibility testing.Zhongshen coordinated with the testing institution to re-sample and supplement the manufacturer’s process description,and finally obtained the qualified report within 3 days.

Comparison of Core Compliance Requirements for European Medical Device Imports

Summary of Zhongshen’s Value

The core of importing high-end European medical devices is "compliance pre-positioning + process connection".Zhongshen avoids 90% of customs clearance risks by pre-checking documents in advance,shortens the customs clearance time by 3 to 7 days by coordinating with customs and commodity inspection departments,and also assists enterprises in handling foreign exchange receipt and payment in accordance with the "Trade Foreign Exchange Receipt and Payment Convenience" policy.Last year,it helped customers save an average of 2% of exchange rate difference costs.For local medical enterprises in Tianjin,choosing a professional agency can not only solve specific operational problems,but also avoid order delays or goods return losses caused by compliance mistakes.